standard]
MAETPQRWWLLLLVSTYLAATIVASTLESSPATKTYIVYMDKWAKPQEFS
DHRQWYSSMIKSVASSRTEKRDDADENDDRIIYNYQTAFHGVAAQLSEEE
VEKLLEQDGVMAVFPETVYHLHTTRSPLFLGLEREDSTSAFTDKLSDYDV
VVGVLDTGIWPESPSFNDTGMSRIPPHWKGTCETGRGFSRHNCNRKIVGA
RVFYRGYEAASGKINEQEEFKSPRDQDGHGTHTAATVAGSPVRGANLLGY
AYGTARGMAPGARIAAYKVCWTGGCFSSDILSAMDQAVADGVNVLSISLG
GGVSSYYRDSLSIGAFGAMERGVLISCSAGNGGPDPISLTNVSPWVTTVG
ASTMDRDFPATIKLGTGKFFTGASLYKGKRNLAVNKQYPLVYHGSNSSNL
TPSSMCLEGTLDRHSVAGKIVICDRGISPRVQKGQVVKDAGGVGMILSNT
AVNGEELVADCHLLPAVAVGETMGKMIKHYAASNHNATATLAFLGTKLRI
RPSPVVAAFSSRGPNILSLEILKPDMIAPGVNILAAWTGELGPSSLPSDH
RRTKFNILSGTSMSCPHVSGVAALIKSRHPDWSPAAIKSALMTTAYVHDN
THSPLTDASTAAPSTPYDHGAGHINPLKALDPGLVYDIGAQEYFEFLCAQ
GLTASELQVFSKFSNRTCRHALANSRDLNYPAISAVFPENTNTTVLTLHR
TVTNVGPPVSSYHVVISTFKGASVKVEPSKLDFTGNRKKMTYKITFTTKS
RQSAPEFGSIIWKDGVHRVRSPVVITWLPPL
|
IPR000209; Peptidase S8/S53, subtilisin/kexin/sedolisin IPR003137; Protease-associated domain, PA IPR010259; Proteinase inhibitor I9, subtilisin propeptide IPR022398; Peptidase S8/S53, subtilisin, act |